½ÃÀ庸°í¼­
»óǰÄÚµå
1717652

¼¼°èÀÇ Ã´Ãß ¾Ð¹Ú °ñÀý ½ÃÀå : ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м®(2025-2031³â) :MedCore

Vertebral Compression Fracture Market Size, Share, & Trends Analysis | Global | 2025-2031 | MedCore | Includes: Vertebroplasty and Percutaneous Vertebral Augmentation Markets

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: iData Research Inc. | ÆäÀÌÁö Á¤º¸: ¿µ¹® 72 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°è ôÃß ¾Ð¹Ú °ñÀý(VCF) ½ÃÀå ±Ô¸ð´Â 2024³â¿¡ 11¾ï ´Þ·¯¸¦ ³Ñ¾ú½À´Ï´Ù.

ÀÌ º¸°í¼­´Â µÎ °¡Áö ÁÖ¿ä ºÎ¹®À» ´Ù·ì´Ï´Ù.

  • °æÇÇÀû ôÃßÁõ´ë¼ú(PVA)
  • ôÃß ¼ºÇü¼ú

Æ÷ÇÔµÈ ½ÃÀå µ¥ÀÌÅÍ

  • ÆÇ¸Å ´ë¼ö
  • Æò±Õ ÆÇ¸Å °¡°Ý(ASP)
  • ½ÃÀå ±Ô¸ð ¹× ¼ºÀå µ¿Çâ
  • ¼ö¼ú °Ç¼ö
  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀΰú ¾ïÁ¦¿äÀÎ
  • 2031³â±îÁö ½ÃÀå ¿¹Ãø
  • 2024³â±îÁö ½ÇÀû µ¥ÀÌÅÍ
  • ÇÕº´°ú Àμö
  • ±â¾÷ ÇÁ·ÎÆÄÀÏ ¹× Á¦Ç° Æ÷Æ®Æú¸®¿À
  • ÁÖ¿ä °æÀï ºÐ¼®

¼¼°è VCF ½ÃÀå µ¿Çâ

  • ¼ºÀå·üÀº Å©°Ô ´Ù¸£Áö¸¸ Àü Áö¿ª¿¡¼­ ½ÃÀå ¼ºÀåÀÌ ¿¹ÃøµË´Ï´Ù.
    • ¼ºÀå·ü¿¡¼­´Â Áßµ¿ÀÌ ¸®µåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.
    • ´ÙÀ½À¸·Î ¾ÆÇÁ¸®Ä«, ¾Æ½Ã¾ÆÅÂÆò¾çÀÌ µÇ°í ÀÖ½À´Ï´Ù.
    • ºÏ¹Ì´Â ½ÃÀåÀÇ ¼º¼÷µµ¸¦ ¹Ý¿µÇÏ¿© °¡Àå ³·Àº ¼ºÀå·ü ¿¹ÃøÀÌ µÇ°í ÀÖ½À´Ï´Ù.
    • ¼­À¯·´µµ ¸¶Âù°¡Áö·Î ¼º¼÷Çϰí ÀÖ½À´Ï´Ù¸¸, ÀÎÇÁ¶ó°¡ È®½ÇÈ÷ Çϰí Àֱ⠶§¹®¿¡ ¼¼°è Á¦3À§¿¡ ·©Å©µÇ°í ÀÖ½À´Ï´Ù.
  • ¼º¼÷µµ°¡ ³·Àº Áö¿ª ½ÃÀå ¼ºÀåÀº Áø´Ü Áõ°¡, ³ëÀÎ Àα¸ Áõ°¡, ¼ö¼ú ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¾×¼¼½º °³¼±¿¡ ÀÇÇØ ÃÊ·¡µË´Ï´Ù.

¼¼°è VCF ½ÃÀå Á¡À¯À²

  • Medtronic
    • 2024³â ½ÃÀå ÀüüÀÇ 50% °¡±îÀ̸¦ Â÷ÁöÇÏ´Â ¼¼°è ½ÃÀåÀÇ ¸®´õ
    • ºÏ¹Ì¿Í ¼­À¯·´¿¡¼­ °­ÇÑ ¿ìÀ§¼º
    • KyphX(R) ½Ã½ºÅÛÀ» Á¦°øÇÏ°í ¿©·¯ ±¹°¡¿¡¼­ PVA ºÎ¹®À» ¼±µµ
  • Stryker
    • VCF ½ÃÀå¿¡¼­ ¼¼°è 2À§
    • Á¦Ç°Àº ´ÙÀ½°ú °°½À´Ï´Ù :
      • AutoPlex(TM) ½Ã¸àÆ® ¹Í¼­ ¹× °ø±Þ ½Ã½ºÅÛ
      • VertaPlex(TM), VertaPlex HV(TM), SpinePlex(R) »À ½Ã¸àÆ®
      • iVAS(TM) PVA ½Ã½ºÅÛ
      • AVAflex dz¼± ½Ã½ºÅÛ ¹× AVAmax(R)
    • °æÀï»ç¿¡ ºñÇØ ºñ¿ë È¿À²ÀûÀÎ ´ëüǰ°ú »ç¿ë ¿ëÀ̼ºÀ¸·Î ¾Ë·ÁÁ® ÀÖ½À´Ï´Ù.
  • DePuy Synthes
    • 2024³â ½ÃÁ¡¿¡¼­ ¼¼°è Á¦3À§ÀÇ °æÀï ±â¾÷
    • Á¦Ç° Æ÷Æ®Æú¸®¿À´Â ´ÙÀ½°ú °°½À´Ï´Ù:
      • CONFIDENCE(TM) ôÃß ½Ã¸àÆ® ½Ã½ºÅÛ
      • VERTECEM(TM) V »À ½Ã¸àÆ®
      • ºÏ¹Ì¿Í ¼­À¯·´¿¡¼­ °­ÇÑ Á¸Àç°¨
      • ÃßüÁõ´ë¼ú¿¡¼­ÀÇ Àü´Þ Á¦¾î¿Í ¾ÈÁ¤¼º¿¡ ÁÖ·Â

½ÃÀå ¼¼ºÐÈ­ ¿ä¾à

  • ôÃß ¼ºÇü¼ú
  • °æÇÇÀû ôÃßÁõ´ë¼ú(PVA)

Á¶»ç ¹üÀ§ ¿ä¾à

  • ´ë»ó Áö¿ª
    • ºÏ¹Ì: ij³ª´Ù, ¹Ì±¹
    • ¶óƾ¾Æ¸Þ¸®Ä« : ¾Æ¸£ÇîÆ¼³ª, º¼¸®ºñ¾Æ, ºê¶óÁú, Ä¥·¹, ÄÝ·Òºñ¾Æ, ÄÚ½ºÅ¸¸®Ä«, µµ¹Ì´ÏÄ« °øÈ­±¹, ¿¡Äâµµ¸£, °úÅ׸»¶ó, ¸ß½ÃÄÚ, ÆÄ³ª¸¶, ÆÄ¶ó°úÀÌ, Æä·ç, Ǫ¿¡¸£Å丮ÄÚ, ¿ì·ç°úÀÌ, º£³×¼ö¿¤¶ó
    • ¼­À¯·´ : ¿À½ºÆ®¸®¾Æ, º£³×·è½º, ÇÁ¶û½º, µ¶ÀÏ, ÀÌÅ»¸®¾Æ, Æ÷¸£Åõ°¥, ½ºÄ­µð³ªºñ¾Æ, ½ºÆäÀÎ, ½ºÀ§½º, ¿µ±¹
    • ÁßÀ¯·´ ¹× µ¿À¯·´ : ¾ÆÁ¦¸£¹ÙÀÌÀÜ, ¹ßÆ® »ï±¹, º§·Î·ç½Ã, ºÒ°¡¸®¾Æ, Å©·Î¾ÆÆ¼¾Æ, üÄÚ °øÈ­±¹, Á¶Áö¾Æ, ±×¸®½º, Çë°¡¸®, Ä«ÀÚÈ彺ź, Æú¶õµå, ·ç¸¶´Ï¾Æ, ·¯½Ã¾Æ, ¼¼¸£ºñ¾Æ, ½½·Î¹ÙŰ¾Æ, ½½·Îº£´Ï¾Æ, Æ¢¸£Å°¿¹, ¿ìÅ©¶óÀ̳ª
    • Áßµ¿ : ¹Ù·¹ÀÎ, À̶õ, À̽º¶ó¿¤, Äí¿þÀÌÆ®, ¿À¸¸, īŸ¸£, »ç¿ìµð¾Æ¶óºñ¾Æ, ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
    • ¾Æ½Ã¾ÆÅÂÆò¾ç: È£ÁÖ, įº¸µð¾Æ, Áß±¹, È«Äá, Àεµ, Àεµ³×½Ã¾Æ, ÀϺ», ۸£±â½º½ºÅº, ¸¶Ä«¿À, ¸»·¹À̽þÆ, ¸ù°ñ, ¹Ì¾á¸¶, ´ºÁú·£µå, ÆÄŰ½ºÅº, Çʸ®ÇÉ, ½Ì°¡Æ÷¸£, Çѱ¹, ½º¸®¶ûÄ«, ´ë¸¸, ű¹, ¿ìÁŰ½ºÅº, º£Æ®³²
    • ¾ÆÇÁ¸®Ä«: ¾ËÁ¦¸®, ÀÌÁýÆ®, ¿¡Æ¼¿ÀÇǾÆ, °¡³ª, ÄɳÄ, ¸®ºñ¾Æ, ¸ð·ÎÄÚ, ³ªÀÌÁö¸®¾Æ, ³²¾ÆÇÁ¸®Ä«, ¼ö´Ü, ¿ì°£´Ù
  • ±âÁØ¿¬µµ : 2024³â
  • ¿¹Ãø ±â°£ : 2025-2031³â
  • °ú°Å µ¥ÀÌÅÍ : 2021-2023³â

Á¤·® µ¥ÀÌÅÍ

  • ¼ö¼ú °Ç¼ö
  • ½ÃÀå ±Ô¸ð
  • ½ÃÀå Á¡À¯À²
  • ½ÃÀå ¿¹Ãø
  • ½ÃÀå ¼ºÀå·ü
  • ÆÇ¸Å ´ë¼ö
  • Æò±Õ ÆÇ¸Å °¡°Ý

ÁúÀû µ¥ÀÌÅÍ

  • ½ÃÀå ¼ºÀå µ¿Çâ
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
  • °æÀï ºÐ¼®
  • ÇÕº´Àμö
  • ±â¾÷ ÇÁ·ÎÆÄÀÏ
  • Á¦Ç° Æ÷Æ®Æú¸®¿À
  • FDA ¸®ÄÝ
  • ÆÄ±«Àû ±â¼ú

µ¥ÀÌÅÍ ¼Ò½º

  • ¾÷°è ¸®´õ¿ÍÀÇ 1Â÷ ÀÎÅͺä
  • Á¤ºÎ ÀÇ»ç µ¥ÀÌÅÍ
  • ±ÔÁ¦ µ¥ÀÌÅÍ
  • º´¿ø µ¥ÀÌÅÍ
  • ¼öÃâÀÔ µ¥ÀÌÅÍ
  • »ç³» µ¥ÀÌÅͺ£À̽º

ÀÌ º¸°í¼­´Â ¼¼°èÀÇ Ã´Ãß ¾Ð¹Ú °ñÀý ½ÃÀå¿¡ ´ëÇØ Á¶»çÇßÀ¸¸ç, ½ÃÀå °³¿ä¿Í ÇÔ²² ½ÃÀå ºÐ¼®°ú ¿¹Ãø, ÃËÁø¿äÀΰú ¾ïÁ¦¿äÀÎ, °æÀï ±¸µµ µîÀ» Á¦°øÇÕ´Ï´Ù.

¸ñÂ÷

ôÃß ¾Ð¹Ú °ñÀý ½ÃÀå

ÁÖ¿ä ¿ä¾à

  • °³¿ä : ¼¼°èÀÇ Ã´Ãß ¾Ð¹Ú °ñÀý ½ÃÀå
  • °æÀï ºÐ¼®
  • ½ÃÀå ¼¼ºÐÈ­
  • ´ë»ó Áö¿ª

¼Ò°³

  • °æÇÇÀû ôÃß ¼ºÇü¼ú
  • PVA(Ãßü ¼ºÇü¼ú Æ÷ÇÔ)

¼ö±â °Ç¼ö

  • ÀüôÃ߾йڰñÀý ¼ö¼ú
  • ôÃß ¼ºÇü¼ú
  • °æÇÇÀû ôÃßÁõ´ë¼ú

½ÃÀå °³¿ä

  • ºÎ¹®º°
  • Áö¿ªº°

½ÃÀå ºÐ¼® ¹× ¿¹Ãø

  • ÀüôÃ߾йڰñÀý½ÃÀå
  • ôÃß¼ºÇü¼ú ½ÃÀå
  • °æÇÇÀû ôÃßÁõ´ë¼ú ½ÃÀå

ÃËÁø¿äÀΰú ¾ïÁ¦¿äÀÎ

°æÀï ½ÃÀå Á¡À¯À² ºÐ¼®

JHS 25.05.23

The global VCF market was valued at over $1.1 billion in 2024.

It is projected to grow at a CAGR of 5.2%, reaching over $1.6 billion by 2031.

The report covers two primary segments:

  • Percutaneous Vertebral Augmentation (PVA)
  • Vertebroplasty

Market Data Included

  • Unit Sales
  • Average Selling Prices (ASPs)
  • Market Size & Growth Trends
  • Procedure Numbers
  • Market Drivers & Limiters
  • Market Forecasts to 2031
  • Historical Data to 2024
  • Mergers & Acquisitions
  • Company Profiles and Product Portfolios
  • Leading Competitor Analysis

Global VCF Market Trends

  • All regions are projected to experience market growth, though the rate of growth varies significantly:
    • Middle East is expected to lead in growth rate.
    • Followed by Africa and Asia-Pacific.
    • North America has the lowest growth forecast, reflecting market maturity.
    • Western Europe is similarly mature but ranks third globally due to its strong infrastructure.
  • Market growth in less mature regions is driven by increased diagnosis, rising elderly populations, and better access to surgical solutions.

Global VCF Market Share Insights

  • 1 Medtronic
    • Global market leader in 2024, holding close to 50% of the total market value.
    • Strong dominance in North America and Western Europe.
    • Offers the KyphX(R) system and leads the PVA segment in multiple countries.
  • 2 Stryker
    • Ranked second globally in the VCF market.
    • Products include:
      • AutoPlex(TM) cement mixer and delivery system
      • VertaPlex(TM), VertaPlex HV(TM), and SpinePlex(R) bone cements
      • iVAS(TM) PVA system
      • AVAflex Balloon System and AVAmax(R)
    • Known for cost-effective alternatives and ease of use compared to competitors.
  • 3 DePuy Synthes
    • Third-largest competitor globally in 2024.
    • Product portfolio includes:
      • CONFIDENCE(TM) Spinal Cement System
      • VERTECEM(TM) V+ bone cement
      • Strong presence in North America and Western Europe.
      • Focused on controlled delivery and stability in vertebral augmentation procedures.

Market Segmentation Summary

  • Vertebroplasty
  • Percutaneous Vertebral Augmentation (PVA)

Research Scope Summary

  • Regions Covered
    • North America: Canada, United States
    • Latin America: Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Guatemala, Mexico, Panama, Paraguay, Peru, Puerto Rico, Uruguay, Venezuela
    • Western Europe: Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, United Kingdom
    • Central & Eastern Europe: Azerbaijan, Baltic States, Belarus, Bulgaria, Croatia, Czech Republic, Georgia, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Serbia, Slovakia, Slovenia, Turkey, Ukraine
    • Middle East: Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates
    • Asia-Pacific: Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Kyrgyzstan, Macao, Malaysia, Mongolia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Sri Lanka, Taiwan, Thailand, Uzbekistan, Vietnam
    • Africa: Algeria, Egypt, Ethiopia, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda
  • Base Year: 2024
  • Forecast Period: 2025-2031
  • Historical Data: 2021-2023

Quantitative Data

  • Procedure Numbers
  • Market Size
  • Market Shares
  • Market Forecasts
  • Market Growth Rates
  • Units Sold
  • Average Selling Prices

Qualitative Data

  • Market Growth Trends
  • Market Limiters
  • Competitive Analysis
  • Mergers & Acquisitions
  • Company Profiles
  • Product Portfolios
  • FDA Recalls
  • Disruptive Technologies

Data Sources

  • Primary Interviews with Industry Leaders
  • Government Physician Data
  • Regulatory Data
  • Hospital Private Data
  • Import & Export Data
  • iData Research Internal Database

TABLE OF CONTENT

Vertebral Compression Fracture Market

  • 9.1 Executive Summary
    • 9.1.1 Global Vertebral Compression Fracture Market Overview
    • 9.1.2 Competitive Analysis
    • 9.1.3 Procedure Segmentation
    • 9.1.4 Market Segmentation
    • 9.1.5 Regions Included
  • 9.2 Introduction
    • 9.2.1 Percutaneous Vertebroplasty
    • 9.2.2 PVA Including Kyphoplasty
  • 9.3 Procedure Numbers
    • 9.3.1 Total Vertebral Compression Fracture Procedures
    • 9.3.2 Vertebroplasty Procedures
    • 9.3.3 Percutaneous Vertebral Augmentation Procedures
  • 9.4 Market Overview
    • 9.4.1 By Segment
    • 9.4.2 By Region
  • 9.5 Market Analysis and Forecast
    • 9.5.1 Total Vertebral Compression Fracture Market
    • 9.5.2 Vertebroplasty Market
    • 9.5.3 Percutaneous Vertebral Augmentation Market
  • 9.6 Drivers and Limiters
    • 9.6.1 Market Drivers
    • 9.6.2 Market Limiters
  • 9.7 Competitive Market Share Analysis
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦